GURBF (Guerbet) FFO


GURBF Guerbet SA GURBF
62 GF Score
Price $22.25
GF Value $49.53
! 5 Warning Signs
View Full Analysis

What is Guerbet FFO?

FFO (Funds from operations) only applies to REITs.

GURBF
62GF Score
Guerbet SA GURBF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guerbet (GURBF) Overvalued in 2026?

Based on GuruFocus' analysis, Guerbet stock appears to be undervalued. The current stock price of $22.25 is trading 55.1% below its estimated GF Value™ of $49.53.

Key valuation signals for GURBF:

  • FFO:
  • GF Value™: $49.53 vs. price of $22.25 (55.1% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the GURBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guerbet Business Description

Address 15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
62GF Score

Get the complete analysis for GURBF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.25
Price
$49.53
GF Value